Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
Jennifer L. Caswell‐Jin(Stanford University), Allison W. Kurian(Stanford University), Jeanne S. Mandelblatt(Georgetown University), Sylvia K. Plevritis(Stanford University), George W. Sledge(Caris Life Sciences (United States)), Christopher J. Cadham(University of Michigan), Lü Tian(Shandong University), Natasha K. Stout(Harvard Pilgrim Health Care), Cong Xu(Stanford University)
Cited by 328
Related Papers
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k